We are live on
!
Find out more
Dr. Reddy's Laboratories
223 hedge funds and large institutions have $1.7B invested in Dr. Reddy's Laboratories in 2023 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 81 increasing their positions, 66 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
5,226% more call options, than puts
Call options by funds: $1.86M | Put options by funds: $35K
150% more funds holding in top 10
Funds holding in top 10: 2 → 5 (+3)
52% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 25
23% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 66
12% more capital invested
Capital invested by funds: $1.51B → $1.7B (+$187M)
7.69% more ownership
Funds ownership: 65.36% → 73.05% (+7.7%)
6% more funds holding
Funds holding: 211 → 223 (+12)
Holders
223
Holders Change
+12
Holders Change %
+5.69%
% of All Funds
3.25%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.07%
New
38
Increased
81
Reduced
66
Closed
25
Calls
$1.86M
Puts
$35K
Net Calls
+$1.83M
Net Calls Change
-$419K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$60.2M |
| 2 |
Man Group
London,
United Kingdom
|
+$51.2M |
| 3 |
BlackRock
New York
|
+$34.6M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$10.6M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$7.79M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$22.9M |
| 2 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$19.1M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$15.8M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$14.7M |
| 5 |
Goldman Sachs
New York
|
-$9.38M |
